Michael Van Kampen
- 4.5 Dobre • 52 opinie
- 36 lat doświadczenia
- Niemcy, Frankfurt nad Menem, Nordwest Clinic (Krankenhaus)
- Specjalista radioterapii
Edukacja i wiedza specjalistyczna
Selcuk University Meram Wydział Lekarski - Edukacja Medyczna
Dr Abdurrahman Yurtaslan Anakara Onkologia Szkoleniowo-Badawczy Szpital Specjalizacja Onkologia Medyczna
Doświadczenie
Klinika Chorób Wewnętrznych Szpitala Państwowego w Malatyi
Klinika Onkologii Medycznej w Szpitalu Onkologicznym w Ankarze
Szpital Erzurum Regional Training and Research Clinic onkologii medycznej
OBSZARY ZAINTERESOWANIA
Rak płuc
rak przełyku
Rak żołądka
rak piersi
Chirurgia przewodu pokarmowego
https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr
Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.
Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.
Dziedziny studiów i zainteresowania
Rak piersi
Rak płuc
Rak jelita grubego
Rak żołądka
Rak odbytnicy
Rak jajnika
Rak macicy
Rak wątroby
Rak przełyku - Rak przełyku
Rak nerki
Rak krtani - Rak gardła
Rak tarczycy
Nowotwory głowy i szyi
Nowotwory ginekologiczne
Rak trzustki
Rak przełyku - Rak przełyku
Rak macicy
Rak mózgu - Guzy mózgu
Rak tkanek miękkich - mięsaki
Rak prostaty
Rak pęcherza moczowego
Rak dróg żółciowych
Rak jąder
Rak szyjki macicy
Rak jamy ustnej, języka i warg
Nowotwory układu pokarmowego
Guzy kości
Rak tchawicy i oskrzeli
Rak skóry - Rak skóry
Guzy układu kostnego
Rak pęcherzyka żółciowego
Mezotelioma
Edukacja
Wydział Lekarski Uniwersytetu Cumhuriyet, 2004
Szpital Edukacyjno-Badawczy Haydarpaşa w Stambule, specjalista chorób wewnętrznych, 2010 r.
Uniwersytet Techniczny Karadeniz, Wydział Lekarski, Specjalista onkologii medycznej, 2015
Kariera
Centrum Onkologiczne MD Andeson, USA, 2008
Klinika onkologii piersi Sunnybrook Odette Cancer Center, Kanada, 2017
Moffit Cancer Center, USA 2022
Szpital Edukacyjno-Badawczy Haydarpaşa w Stambule, Medycyna Wewnętrzna, 2010
Klinika chorób wewnętrznych Szpitala Państwowego w Idil, 2011 r.
Wydział Lekarski Uniwersytetu Technicznego Karadeniz, Klinika Onkologii Klinicznej, 2015
Klinika onkologii medycznej w szpitalu badawczym i edukacyjnym w Stambule Göztepe, 2018 r.
Uniwersytet Yeniyüzyıl Szpital Gaziosmanpaşa Klinika Onkologii Medycznej, 2020
Szpital Ataşehir Medicana, Klinika Onkologii Medycznej, 2022
Univ.-Prof. Dr. Wolfgang Johannes Köstler jest certyfikowanym specjalistą w zakresie medycyny wewnętrznej, hematologii/onkologii i intensywnej terapii, który specjalizuje się w hematologii i onkologii wewnętrznej oraz intensywnej terapii. Jest jednym z najlepiej ocenianych specjalistów onkologów zajmujących się rakiem piersi i mięsakami, ma duże doświadczenie w tej dziedzinie i uzyskał dyplomy na Uniwersytecie Medycznym w Wiedniu i Instytucie Nauki Weizmanna. Ukończył również specjalistyczne szkolenie w Memorial Sloan-Kettering Cancer Center i Royal Prince Alfred Hospital.
Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.
Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Onkoginekolog, specjalista operacji laparoskopowych
Dr. Inta Jaunalksne is an experienced immunologist with more than 30 years in the field. She specializes in virotherapy. She graduated from Riga Medical Institute and completed an internship in Internal Medicine. Dr. Jaunalksne is recognized as an expert in immunology.
She leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital. Dr. Jaunalksne has played a key role in advancing virotherapy and immunological research. Her work has improved treatment results and introduced new therapies. She is well respected in clinical immunology.
Dr. Serap Kaya is a medical oncologist with a specialization in Medical Oncology from Kocaeli University Faculty of Medicine. She has worked at several leading hospitals, including Oltu State Hospital, Kocaeli State Hospital, Marmara University Pendik Training and Research Hospital, and Medistate Kavacik Hospital. Dr. Kaya has made important contributions to cancer care at these institutions.
She is known for her evidence-based approach and focus on patient outcomes. Dr. Kaya has managed many complex oncology cases. She holds accreditation from top Turkish medical faculties. Dr. Kaya is committed to improving oncology practice through ongoing professional development and clinical excellence.
Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.
Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.
Dr Tamar Jablonski-Perec jest onkologiem w Hadassah Medical Center w Jerozolimie. Posiada tytuł doktora nauk medycznych Uniwersytetu Hebrajskiego i doświadczenie zdobyte w renomowanym Sloan-Kettering Cancer Center w Nowym Jorku. Jest kierownikiem Instytutu Onkologii, kierownikiem Breast Cancer Treatment Center i profesorem Wydziału Onkologii na Uniwersytecie Hebrajskim. Jest członkiem kilku międzynarodowych społeczności onkologicznych i otrzymała stypendium od Hadassah Medical School.
Dr. Shaunak Valame is an MD in Internal Medicine and holds a DNB in Medical Oncology. He received advanced training at Indraprastha Apollo Hospital in New Delhi. He also worked as a Registrar at Jawaharlal Nehru Cancer Hospital in Bhopal. Dr. Valame has presented his research at international forums, including the Gastrointestinal Cancer Symposium in San Francisco.
He is known for his work in targeted cancer therapies. He has given lectures at the International Winter School of Oncology at AIIMS Bhopal. Dr. Valame is accredited by the American Society of Clinical Oncology. He is committed to advancing cancer research and clinical care.